Francisco Silva
CIK: 0001527241
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRTX
BioRestorative Therapies, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Silva Francisco
Silva Francisco (SEC CIK 0001527241) files insider reports with the SEC as VP of Research and Development of BioRestorative Therapies, Inc. (BRTX).
Signal8 holds 2 ownership filings by Silva Francisco, all Form 4s, filed between Feb 19, 2025 and Oct 20, 2025. Those filings report 2 transactions, from Feb 14, 2025 to Oct 6, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Silva Francisco's filings is in MELVILLE, NY.
Recent filings by Silva Francisco
Other insiders filing for BioRestorative Therapies, Inc. (BRTX)
- Randhawa Esha, Director
- Grasso Mika, Director
- Dhaliwal Jatinder, Director
- Field Katharyn, Director
- ALSTODT LANCE, President, CEO, COB
- Rosa David A, Director